Medtronic logo

Leading Innovation.

For more than 30 years,
Medtronic has been
committed to
diabetes care.

Our goal for the future is aimed at developing technologies that are:


Simplify everyday diabetes management


Create more discreet products


Develop predictive analytics that adapt to individual needs

*In comparison with our previous models/products.

A History of Firsts


1st pump system with personalised selectable targets


1st smartphone connected system to automatically self-adjust background insulin


1st stand-alone Smart† CGM with predictive alerts


1st system to automatically adjust background insulin‡


1st technology to help reduce lows


1st technology to help reduce severe lows


1st technology to integrate pump & CGM

† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance.
‡ Refers to SmartGuardTM Auto Mode. Some user interaction required Individual results may vary.

Future Product Innovations

Advanced Algorithm Enhancements

Our goal is to keep evolving our algorithms to provide correction for when carb counting isn't exact. Our goal is to add flexibility to the glucose target range goals and help stabilise blood sugar with less effort.

Infusion Set Evolution

Our goal is to design longer wear infusion sets to reduce insertion pokes and simplify the overall daily diabetes management.

Enhanced Sensor Technology^

Our goal for our sensors is to simplify the overall experience by increasing the length of sensor wear, reducing punctures and calibrations, while providing more discreet and disposable options.

Smarter CGM^

We are working on future technology with the goal of personalising insulin dosing suggestions using predictive analytics. Adding flexibility to optimise predictive low/high alerts while showing impact of treatment and activity decisions.

Improving Personalised Insulin Delivery^

Our insulin pump system's goal is to be able to adapt to the body’s physiology and behaviour by learning from activity patterns to self-adjust insulin. Imagine a system that predicts which activity has been performed and estimates the body’s insulin need!

Combined Consumables^

Our goal is to design an all-in-one sensor, transmitter and infusion set with longer wear and with a single insertion.

◊ Investigational. Not approved for any use and not commercially available in Australia.
^ In development. Potential future technology. Not approved and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of Australia and not guaranteed.

For detailed information regarding indications, contraindications, warnings, precautions, and potential adverse effects, please consult the IFU. Always consult a Health Care Professional before making treatment decisions, and to see if this product is suitable for you.


Medtronic continues to work on delivering new technologies to help individuals manage their diabetes. To make these upgrades easily accessible, we are developing technology to update our pump through a software download.'

*New technology described is not currently available for sale in Australia. Any new products are subject to regulatory approval. Offer subject to change without notice.